Lrp5 functions in bone to regulate bone mass (original) (raw)

• Gong, Y. et al. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107, 513–523 (2001).
  Article CAS Google Scholar
• Little, R.D. et al. A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am. J. Hum. Genet. 70, 11–19 (2002).
  Article CAS Google Scholar
• Boyden, L.M. et al. High bone density due to a mutation in LDL-receptor-related protein 5. N. Engl. J. Med. 346, 1513–1521 (2002).
  Article CAS Google Scholar
• Balemans, W. et al. Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum. Mol. Genet. 10, 537–543 (2001).
  Article CAS Google Scholar
• Brunkow, M.E. et al. Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. Am. J. Hum. Genet. 68, 577–589 (2001).
  Article CAS Google Scholar
• Morello, R. et al. CRTAP is required for prolyl 3-hydroxylation and mutations cause recessive osteogenesis imperfecta. Cell 127, 291–304 (2006).
  Article CAS Google Scholar
• Ai, M., Heeger, S., Bartels, C.F. & Schelling, D.K. Clinical and molecular findings in osteoporosis-pseudoglioma syndrome. Am. J. Hum. Genet. 77, 741–753 (2005).
  Article CAS Google Scholar
• Van Wesenbeeck, L. et al. Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density. Am. J. Hum. Genet. 72, 763–771 (2003).
  Article CAS Google Scholar
• Ai, M., Holmen, S.L., Van Hul, W., Williams, B.O. & Warman, M.L. Reduced affinity to and inhibition by DKK1 form a common mechanism by which high bone mass-associated missense mutations in LRP5 affect canonical Wnt signaling. Mol. Cell. Biol. 25, 4946–4955 (2005).
  Article CAS Google Scholar
• Holmen, S.L. et al. Decreased BMD and limb deformities in mice carrying mutations in both Lrp5 and Lrp6. J. Bone Miner. Res. 19, 2033–2040 (2004).
  Article CAS Google Scholar
• Semenov, M.V. & He, X. LRP5 mutations linked to high bone mass diseases cause reduced LRP5 binding and inhibition by SOST. J. Biol. Chem. 281, 38276–38284 (2006).
  Article CAS Google Scholar
• Kato, M. et al. Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J. Cell Biol. 157, 303–314 (2002).
  Article CAS Google Scholar
• Kokubu, C. et al. Skeletal defects in ringelschwanz mutant mice reveal that Lrp6 is required for proper somitogenesis and osteogenesis. Development 131, 5469–5480 (2004).
  Article CAS Google Scholar
• Nakanishi, R. et al. Secreted frizzled-related protein 4 is a negative regulator of peak BMD in SAMP6 mice. J. Bone Miner. Res. 21, 1713–1721 (2006).
  Article CAS Google Scholar
• Li, X. et al. Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength. J. Bone Miner. Res. 23, 860–869 (2008).
  Article Google Scholar
• Morvan, F. et al. Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass. J. Bone Miner. Res. 21, 934–945 (2006).
  Article CAS Google Scholar
• Babij, P. et al. High bone mass in mice expressing a mutant LRP5 gene. J. Bone Miner. Res. 18, 960–974 (2003).
  Article CAS Google Scholar
• Zhang, Y. et al. The LRP5 high-bone-mass G171V mutation disrupts LRP5 interaction with Mesd. Mol. Cell. Biol. 24, 4677–4684 (2004).
  Article CAS Google Scholar
• Maretto, S. et al. Mapping Wnt/β-catenin signaling during mouse development and in colorectal tumors. Proc. Natl. Acad. Sci. USA 100, 3299–3304 (2003).
  Article CAS Google Scholar
• Jho, E.H. et al. Wnt/β-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol. Cell. Biol. 22, 1172–1183 (2002).
  Article CAS Google Scholar
• Lu, Y. et al. DMP1-targeted Cre expression in odontoblasts and osteocytes. J. Dent. Res. 86, 320–325 (2007).
  Article CAS Google Scholar
• Yadav, V.K. et al. Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell 135, 825–837 (2008).
  Article CAS Google Scholar
• Liu, Q. et al. Discovery and characterization of novel tryptophan hydroxylase inhibitors that selectively inhibit serotonin synthesis in the gastrointestinal tract. J. Pharmacol. Exp. Ther. 325, 47–55 (2008).
  Article CAS Google Scholar
• Walther, D.J. et al. Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science 299, 76 (2003).
  Article CAS Google Scholar
• Alenina, N. et al. Growth retardation and altered autonomic control in mice lacking brain serotonin. Proc. Natl. Acad. Sci. USA 106, 10332–10337 (2009).
  Article CAS Google Scholar
• Savelieva, K.V. et al. Genetic disruption of both tryptophan hydroxylase genes dramatically reduces serotonin and affects behavior in models sensitive to antidepressants. PLoS ONE 3, e3301 (2008).
  Article Google Scholar
• Madison, B.B. et al. Cis elements of the villin gene control expression in restricted domains of the vertical (crypt) and horizontal (duodenum, cecum) axes of the intestine. J. Biol. Chem. 277, 33275–33283 (2002).
  Article CAS Google Scholar
• Logan, M. et al. Expression of Cre recombinase in the developing mouse limb bud driven by a Prxl enhancer. Genesis 33, 77–80 (2002).
  Article CAS Google Scholar
• Iwaniec, U.T. et al. PTH stimulates bone formation in mice deficient in Lrp5. J. Bone Miner. Res. 22, 394–402 (2007).
  Article CAS Google Scholar
• Long, F. When the gut talks to bone. Cell 135, 795–796 (2008).
  Article CAS Google Scholar
• Rosen, C.J. Serotonin rising—the bone, brain, bowel connection. N. Engl. J. Med. 360, 957–959 (2009).
  Article CAS Google Scholar
• Yadav, V.K. et al. Pharmacological inhibition of gut-derived serotonin synthesis is a potential bone anabolic treatment for osteoporosis. Nat. Med. 16, 308–312 (2010).
  Article CAS Google Scholar
• Balemans, W. et al. The binding between sclerostin and LRP5 is altered by DKK1 and by high-bone mass LRP5 mutations. Calcif. Tissue Int. 82, 445–453 (2008).
  Article CAS Google Scholar
• Ellies, D.L. et al. Bone density ligand, Sclerostin, directly interacts with LRP5 but not LRP5G171V to modulate Wnt activity. J. Bone Miner. Res. 21, 1738–1749 (2006).
  Article CAS Google Scholar
• MacDonald, B.T. et al. Bone mass is inversely proportional to Dkk1 levels in mice. Bone 41, 331–339 (2007).
  Article CAS Google Scholar
• Robling, A.G. et al. Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin. J. Biol. Chem. 283, 5866–5875 (2008).
  Article CAS Google Scholar
• Bonewald, L.F. & Johnson, M.L. Osteocytes, mechanosensing and Wnt signaling. Bone 42, 606–615 (2008).
  Article CAS Google Scholar
• Robinson, J.A. et al. Wnt/β-catenin signaling is a normal physiological response to mechanical loading in bone. J. Biol. Chem. 281, 31720–31728 (2006).
  Article CAS Google Scholar
• Sawakami, K. et al. The Wnt co-receptor LRP5 is essential for skeletal mechanotransduction but not for the anabolic bone response to parathyroid hormone treatment. J. Biol. Chem. 281, 23698–23711 (2006).
  Article CAS Google Scholar
• Dong, Y. et al. Molecular cloning and characterization of LR3, a novel LDL receptor family protein with mitogenic activity. Biochem. Biophys. Res. Commun. 251, 784–790 (1998).
  Article CAS Google Scholar
• Fuccillo, M., Joyner, A.L. & Fishell, G. Morphogen to mitogen: the multiple roles of hedgehog signalling in vertebrate neural development. Nat. Rev. Neurosci. 7, 772–783 (2006).
  Article CAS Google Scholar
• Zhong, W. & Chia, W. Neurogenesis and asymmetric cell division. Curr. Opin. Neurobiol. 18, 4–11 (2008).
  Article Google Scholar
• Day, T.F., Guo, X., Garrett-Beal, L. & Yang, Y. Wnt/β-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev. Cell 8, 739–750 (2005).
  Article CAS Google Scholar
• Hill, T.P., Spater, D., Taketo, M.M., Birchmeier, W. & Hartmann, C. Canonical Wnt/β-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev. Cell 8, 727–738 (2005).
  Article CAS Google Scholar
• Hu, H. et al. Sequential roles of Hedgehog and Wnt signaling in osteoblast development. Development 132, 49–60 (2005).
  Article CAS Google Scholar
• Kang, S. et al. Wnt signaling stimulates osteoblastogenesis of mesenchymal precursors by suppressing CCAAT/enhancer-binding protein alpha and peroxisome proliferator-activated receptor gamma. J. Biol. Chem. 282, 14515–14524 (2007).
  Article CAS Google Scholar
• Kelly, O.G., Pinson, K.I. & Skarnes, W.C. The Wnt co-receptors Lrp5 and Lrp6 are essential for gastrulation in mice. Development 131, 2803–2815 (2004).
  Article CAS Google Scholar
• Dacquin, R., Starbuck, M., Schinke, T. & Karsenty, G. Mouse alpha1(I)-collagen promoter is the best known promoter to drive efficient Cre recombinase expression in osteoblast. Dev. Dyn. 224, 245–251 (2002).
  Article CAS Google Scholar
• Ingebretsen, O.C., Bakken, A.M. & Farstad, M. Liquid chromatography of serotonin and adenine nucleotides in blood platelets, illustrated by evaluation of functional integrity of platelet preparations. Clin. Chem. 31, 695–698 (1985).
  CAS PubMed Google Scholar
• Anderson, G.M., Stevenson, J.M. & Cohen, D.J. Steady-state model for plasma free and platelet serotonin in man. Life Sci. 41, 1777–1785 (1987).
  Article CAS Google Scholar
• Wolff, J. The Law of Bone Remodeling (Springer-Verlag, 1892).
• Lakso, M. et al. Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. Proc. Natl. Acad. Sci. USA 93, 5860–5865 (1996).
  Article CAS Google Scholar
• Farley, F.W., Soriano, P., Steffen, L.S. & Dymecki, S.M. Widespread recombinase expression using FLPeR (flipper) mice. Genesis 28, 106–110 (2000).
  Article CAS Google Scholar
• Schwenk, F., Baron, U. & Rajewsky, K. A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res. 23, 5080–5081 (1995).
  Article CAS Google Scholar
• Clément-Lacroix, P. et al. Lrp5-independent activation of Wnt signaling by lithium chloride increases bone formation and bone mass in mice. Proc. Natl. Acad. Sci. USA 102, 17406–17411 (2005).
  Article Google Scholar
• Muzumdar, M.D., Tasic, B., Miyamichi, K., Li, L. & Luo, L. A global double-fluorescent Cre reporter mouse. Genesis 45, 593–605 (2007).
  Article CAS Google Scholar
• Tenner, K., Qadri, F., Bert, B., Voigt, J.P. & Bader, M. The mTPH2 C1473G single nucleotide polymorphism is not responsible for behavioural differences between mouse strains. Neurosci. Lett. 431, 21–25 (2008).
  Article CAS Google Scholar